Open Access

Time to reduce the implementation gaps-the role of PCSK9i in routine practice

Topic: Treatment
Organised by PACE-CME, supported by Amgen and Sanofi in the form of an educational grant

Presentation

About the speaker

Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
48 presentations
1 follower

4 more presentations in this session

Introduction.

Speaker: Professor J. Kastelein (Amsterdam, NL)

Thumbnail

One year after: what are the implications of the new The ESC/EAS LDL-c Guidelines for PCSK9i?

Speaker: Professor F. Mach (Geneva, CH)

Thumbnail

Five years of PCSK9i: Lessons from practice, which patients do benefit most?

Speaker: Professor E. Stroes (Amsterdam, NL)

Thumbnail

Discussion.

Speaker: Professor J. Kastelein (Amsterdam, NL)

Thumbnail

Access the full session

PCSK9i & LDL-c: Guidelines, Practice & Innovation: Review of facts and opportunities

Speakers: Professor K. Ray, Professor J. Kastelein, Professor F. Mach, Professor E. Stroes, Professor J. Kastelein
Thumbnail

About the event

Image

ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

This platform is supported by

logo Novo Nordisk